159 related articles for article (PubMed ID: 38013514)
21. [Focus on multi-morbidity patients. Considering the greatest measure of therapy safety].
MMW Fortschr Med; 2007 Dec; 149(49-50):59. PubMed ID: 18236986
[No Abstract] [Full Text] [Related]
22. Acid control and regression of Barrett's esophagus: is the glass half full or half empty?
Castell DO; Katz PO
Am J Gastroenterol; 1997 Dec; 92(12):2329-30. PubMed ID: 9399786
[No Abstract] [Full Text] [Related]
23. Safety profile of the proton-pump inhibitors.
Reilly JP
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S11-7. PubMed ID: 10597119
[TBL] [Abstract][Full Text] [Related]
24. [Proton pump inhibitors in pediatrics].
Faure C; Pelatan C; Languepin J
Arch Pediatr; 1999 Jun; 6(6):650-6. PubMed ID: 10394458
[TBL] [Abstract][Full Text] [Related]
25. Review article: long-term use of proton pump inhibitors in GORD--help or hindrance?
Tytgat GN
Aliment Pharmacol Ther; 2001 Sep; 15 Suppl 2():6-9. PubMed ID: 11556874
[TBL] [Abstract][Full Text] [Related]
26. Anaphylaxis to Commonly Used Drug Oral Pantoprazole.
Sharda M; Mittal SK; Gadhwal M; Vijay A
J Assoc Physicians India; 2022 Dec; 70(12):11-12. PubMed ID: 37355982
[No Abstract] [Full Text] [Related]
27. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
28. Pantoprazole: a proton pump inhibitor.
Moreira Dias L
Clin Drug Investig; 2009; 29 Suppl 2():3-12. PubMed ID: 19938880
[TBL] [Abstract][Full Text] [Related]
29. An overview of proton pump inhibitors.
Der G
Gastroenterol Nurs; 2003; 26(5):182-90. PubMed ID: 14603076
[TBL] [Abstract][Full Text] [Related]
30. Is there a dark side to long-term proton pump inhibitor therapy?
Nealis TB; Howden CW
Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
[TBL] [Abstract][Full Text] [Related]
31. The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
Sasakii M; Joh T; Yokoyama Y; Seno K; Tsuchida K; Kurokawa T; Itoh M
J Pharm Pharmacol; 1999 Jul; 51(7):825-30. PubMed ID: 10467958
[TBL] [Abstract][Full Text] [Related]
32. Thyroxine in goiter, H. pylori infection, and gastritis.
Dietrich JW; Boehm BO
N Engl J Med; 2006 Sep; 355(11):1177; author reply 1177. PubMed ID: 16971728
[No Abstract] [Full Text] [Related]
33. [Proton pump blockers and their significance in gastroenterology].
Dítĕ P; Prásek J
Vnitr Lek; 1995 Aug; 41(8):549-54. PubMed ID: 7483340
[TBL] [Abstract][Full Text] [Related]
34. [Clinical pharmacological aspects of the proton pump inhibitor therapy: importance of pharmacogenetic differences in the clinical practice].
Mullner K; Molnar B; Tulassay Z
Orv Hetil; 2007 Mar; 148(12):543-51. PubMed ID: 17444020
[TBL] [Abstract][Full Text] [Related]
35. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
Song TJ; Kim J
PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
[TBL] [Abstract][Full Text] [Related]
36. Intermittent use of pantoprazole and famotidine in severe hypomagnesaemia due to omeprazole.
Fernández-Fernández FJ; Sesma P; Caínzos-Romero T; Ferreira-González L
Neth J Med; 2010 Oct; 68(10):329-30. PubMed ID: 21071783
[No Abstract] [Full Text] [Related]
37. The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis.
Gardner JD; Gallo-Torres H; Sloan S; Robinson M; Miner PB
Aliment Pharmacol Ther; 2003 Nov; 18(9):891-905. PubMed ID: 14616153
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
Welage LS; Berardi RR
J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
[TBL] [Abstract][Full Text] [Related]
39. Alternative method for administering proton-pump inhibitors through nasogastric tubes.
Peckman HJ
Am J Health Syst Pharm; 1999 May; 56(10):1020. PubMed ID: 10365730
[No Abstract] [Full Text] [Related]
40. Helicobacter pylori: factors affecting eradication and recurrence.
Vakil N
Am J Gastroenterol; 2005 Nov; 100(11):2393-4. PubMed ID: 16279890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
